Zivo Bioscience, Inc.
ZIVO· OTC
ZIVOZivo Bioscience, Inc.
Filed Mar 14, 2023 · 10-K · 73 days after period end · 0001654954-23-002845
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$2.64M | -$3.14M | -$1.89M | -$4.13M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR
ended Dec 31, 2022 · filed Mar 14, 2023 · 73 d after period end
